Loading...
Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...
Na minha lista:
| Udgivet i: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754892/ https://ncbi.nlm.nih.gov/pubmed/33037750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13042 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|